Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nirav S. Jhaveri Insider Profile
4 Followers
Nirav S. Jhaveri, CFO at Ocuphire Pharma, holds 150.00K shares in Ocuphire Pharma (Ticker: OCUP). Most recently, Nirav S. Jhaveri Bought $10,000 shares of Ocuphire Pharma on Mar 25, 2024 for an estimated value of 21.00K.
Nirav S. Jhaveri has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Nirav S. Jhaveri's holdings
Insider Roles
CFO
Roles that Nirav S. Jhaveri holds in companies
Most Profitable Insider Trade
The most profitable trade made by Nirav S. Jhaveri
Nirav S. Jhaveri's Trading History
List of latest transactions for each holding click on a transaction to see Nirav S. Jhaveri's performance on stock
You May Also Like
Nirav S. Jhaveri insider profile FAQ
What is the percentage of profitable transactions made by Nirav S. Jhaveri?
The percentage of profitable transactions made by Nirav S. Jhaveri is ―.
What is the average return per transaction made by Nirav S. Jhaveri?
The average return per transaction made by Nirav S. Jhaveri is ―.
What stocks does Nirav S. Jhaveri hold?
Nirav S. Jhaveri holds: OCUP stocks.
What was Nirav S. Jhaveri’s latest transaction?
Nirav S. Jhaveri latest transaction was an Informative Buy of $21.00K.
What was Nirav S. Jhaveri's most profitable transaction?
Nirav S. Jhaveri’s most profitable transaction was an Informative Buy of OCUP stock on March 25, 2024. The return on the trade was -17.80%.
What is Nirav S. Jhaveri's role in Ocuphire Pharma?
Nirav S. Jhaveri's role in Ocuphire Pharma is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.